Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Country deep-dive

Single-country regulatory or market reports. How peptides actually move through Danish customs; what the BfArM said about a specific schedule shift; the German press response to a Mounjaro shortage.

Country deep-dive

Retatrutide in Sweden: no approval yet

Retatrutide holds no EMA or Läkemedelsverket authorisation as of July 2026. Here is where the TRIUMPH trials stand and what that means for Swedish patients.

17 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

Semax in Sweden: regulatory status

Semax has no marketing authorisation in Sweden or the EU. Here is the Läkemedelslagen framework, what changed in 2025-2026, and who to ask.

17 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

TB-500 cost in the Netherlands

TB-500 has no EU marketing authorisation and no Dutch insurance coverage. No verified pharmacy price exists in the Netherlands.

14 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

TB-500 in the Netherlands: legal status

TB-500 has no marketing authorisation in the Netherlands. This page explains how the Geneesmiddelenwet, the CBG-MEB register, and the WADA sport ban apply.

14 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

Tesamorelin Netherlands: import rules

Tesamorelin has no EU marketing authorisation. The Netherlands has no registered product. What Dutch law, CBG-MEB rules, and customs mean for personal import.

14 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

Tesamorelin Netherlands: regulatory status

Tesamorelin has no EU marketing authorisation. The EMA application was withdrawn in 2012. Here is what Dutch patients and clinicians need to know.

14 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

Tirzepatide in Netherlands: Mounjaro access

Mounjaro (tirzepatide) has held an EMA marketing authorisation in the Netherlands since 2022. Here is what the licence covers and how Dutch reimbursement works.

14 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

What Semax costs in the Netherlands

Semax has no EMA or CBG-MEB authorisation, so there is no official Dutch pharmacy price and no GVS reimbursement. Here is what that means for Dutch readers.

13 Jul 2026 · PeptideMethods Editorial Team · 5 min read
Country deep-dive

What BPC-157 costs in Denmark

BPC-157 has no marketing authorisation in Denmark: no official price, no pharmacy route, no reimbursement. What the grey-market reality looks like.

7 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

BPC-157 Denmark: import rules explained

BPC-157 is unauthorised in Denmark. The 2026 personal import rules explicitly restrict doping substances. What the DKMA says and what customs flags.

7 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

What tirzepatide costs in Germany

Cash prices, GKV reimbursement rules, PKV coverage, and the AMNOG process that determines what Mounjaro costs in Germany in 2026.

7 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

Tirzepatide Germany: import rules explained

Tirzepatide is EU-authorised as Mounjaro in Germany. What AMG § 73 says about importing it from outside the EU, grey-market risks, and how to get it legally.

7 Jul 2026 · PeptideMethods Editorial Team · 7 min read